JAK inhibitors bring new hope for hair loss patients
Mankind has long searched for effective solutions for hair loss. An Egyptian medical papyrus from 1550 BC recounts bizarre remedies such as boiled porcupine quills and sautéed canine body parts. Fortunately, today we have science-based research leading to effective new treatments. Center for Dermatology and Dermatologic Surgery, with offices in Washington, DC and Annapolis, MD, is pleased to offer one of the latest – JAK inhibitors for alopecia areata.
About alopecia areata
Alopecia areata is different than a receding hairline, diffuse thinning, or pattern baldness. This type of hair loss causes clumps to fall out, leaving smooth, hairless patches on the scalp or body. In some cases:
- It causes hair to break off into short stubs.
- Complete hair loss (all over the head and body) occurs.
- Hair grows back in one area and falls out in another.
- Hair grows back white and fine.
This condition is triggered by a malfunction of the immune system, mistakenly attacking hair follicles. Men and women under the age of 20 are most commonly affected, but it can occur in children and older adults, too.
About ten percent of those with alopecia areata never regrow hair . . . until now.
Enzymes in the Janus kinase family are receptors, part of the body’s complex signaling method necessary for cellular regeneration. Medications known as Janus kinase inhibitors or jakinibs decrease the activity of these enzymes. JAK inhibitors have been used medically to treat cancer, autoimmune diseases, rheumatoid arthritis, and other inflammatory diseases. Now, studies indicate huge potential for treatment of alopecia areata with JAK inhibitors, and possibly as a cure for hair loss in the future.
While FDA-approval is pending, there are several JAK inhibitors that show great promise, with minimal risk of side effects. Schedule a consultation today to learn more. In Annapolis the number is 410-224-1195, and in Washington call 202-955-5757.